Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258908
Status:
COMPLETED
Last Update Posted:
2016-04-14
First Post:
2005-11-24
Brief Title:
Immunogenicity and Safety of ADACEL as Fifth Dose in Taiwan
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Study Overview
Official Title:
Immunogenicity and Safety of ADACEL TdcP Vaccine as Fifth Dose in Children 6-8 Years of Age
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the immunogenicity profile of ADACEL Tetanus and Diphtheria Toxoids Adsorbed combined with Component Pertussis Vaccine TdcP Vaccine one month after administration
To describe the safety profile of ADACEL TdcP Vaccine when given as a fifth dose
To describe the safety profile of ADACEL TdcP Vaccine when given as a fifth dose
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None